| Autophagy, unfolded protein response, and neuropilin-1 cross-talk in SARS-CoV-2 infection: What can be learned from other coronaviruses M Siri, S Dastghaib, M Zamani, N Rahmani-Kukia, KR Geraylow, S Fakher, ... International Journal of Molecular Sciences 22 (11), 5992, 2021 | 29 | 2021 |
| Targeting miRNAs with anesthetics in cancer: Current understanding and future perspectives P Tabnak, S Masrouri, KR Geraylow, M Zarei, ZH Esmailpoor Biomedicine & Pharmacotherapy 144, 112309, 2021 | 23 | 2021 |
| miRNA expression in COVID-19 KR Geraylow, R Hemmati, S Kadkhoda, S Ghafouri-Fard Gene reports 28, 101641, 2022 | 16 | 2022 |
| A bioengineering method for modeling alveolar Rhabdomyosarcoma and assessing chemotherapy responses E Stefanek, E Samiei, M Kavoosi, M Esmaeillou, KR Geraylow, A Emami, ... MethodsX 8, 101473, 2021 | 13 | 2021 |
| The relationship between demographic features, anthropometric parameters, sleep duration, and physical activity with ECG parameters in Fasa Persian cohort study A Mirahmadizadeh, M Farjam, M Sharafi, H Fatemian, M Kazemi, ... BMC Cardiovascular Disorders 21 (1), 1-11, 2021 | 8 | 2021 |
| Common clinical symptoms and concomitant disease in celiac patients–A large cohort study in the North-East of Iran. A Ganji, KR Geraylow, B Shahbazkhani, F Attarian Journal of Contemporary Medical Sciences 76 (6), 2021 | 5 | 2021 |
| Expansion of a Subset Within the C2 Subclade of Escherichia coli Sequence Type 131 (ST131) Is Driving the Increasing Rates of Aminoglycoside Resistance Z Hojabri, N Darabi, M Mirmohammadkhani, H Rahimi, R Hemmati, ... Open Forum Infectious Diseases 7 (11), ofaa410, 2020 | 5 | 2020 |
| Efficacy of botulinum toxin type A injection for Raynaud’s phenomenon and digital ulcers in patients with systemic sclerosis MH Jokar, B Baghbani, KR Geraylow, J Shariati, H Mehrad-Majd, ... Reumatologia 60 (6), 392, 2022 | 3 | 2022 |
| Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancreatic Cancer F Asgharzadeh, KR Geraylow, M Khazaei, M Nassiri, SM Hassanian, ... Current Cancer Drug Targets 22 (10), 785-795, 2022 | 2 | 2022 |
| Unlocking c-MET: A comprehensive journey into targeted therapies for breast cancer PJ Kaboli, HF Chen, A Babaeizad, KR Geraylow, H Yamaguchi, MC Hung Cancer Letters, 216780, 2024 | 1 | 2024 |
| The effects of low-fat dairy products fortified with 1500 IU vitamin D3 on serum liver function biomarkers in adults with abdominal obesity: a randomized controlled trial P Sharifan, S Darroudi, M Rafiee, K Roustai Geraylow, R Hemmati, ... Journal of Health, Population and Nutrition 42 (1), 102, 2023 | 1 | 2023 |
| Effectiveness of postoperative oral administration of cephalexin and metronidazole on surgical site infection among obese women undergoing cesarean section: a randomized … F Tara, S Danesteh, M Rezaee, KR Geraylow, AA Moodi Ghalibaf, ... Antimicrobial Resistance & Infection Control 11 (1), 150, 2022 | 1 | 2022 |
| Proximal femoral varus osteotomy for Legg–Calvé–Perthes disease: Do age and lateral pillar classifications influence short-to-mid-term clinical and radiological outcomes? N Hoseini-Zare, P Mirghaderi, B Ilharreborde, K Roustai-Geraylow, ... Orthopaedics & Traumatology: Surgery & Research, 103909, 2024 | | 2024 |
| Does Using Highly Porous Tantalum in Revision Total Hip Arthroplasty Reduce the Rate of Periprosthetic Joint Infection? A Systematic Review and Meta-Analysis P Mirghaderi, N Eshraghi, E Sheikhbahaei, M Razzaghof, ... Arthroplasty Today 25, 101293, 2024 | | 2024 |
| miRNA expression in COVID-19. R Hemmati, S Kadkhoda, S Ghafouri-Fard Gene Reports 28, 101641-101641, 2022 | | 2022 |
| Comparative Study of Vascular Endothelial Growth Factor in Exudative and Transudative Pleural Effusion SM Lari, A Akbari, KR Geraylow, S Zarifkia, F Hokmabadi, ... Tanaffos 21 (3), 384, 2022 | | 2022 |
| The relationship between demographic features, anthropometric parameters, sleep hours, and physical activity and ECG parameters in Fasa Persian cohort study A Mirahmadizadeh, M Farjam, M Sharafi, H Fatemian, M Kazemi, ... | | 2021 |
| A Very Well Tolerated and Active Protocol in Advanced and Metastatic Melanoma for Developing Countries in the Immunotherapy Era! R Malayeri, KR Geraylow | | |
| Protocol Article–Title Page E Stefanek, KR Geraylow, A Emami, M Ashrafizadeh, D Perrin | | |
